Tag: MAKI

Image: PD. RSV. 1. Prophylaxis with an anti-respiratory syncytial virus (RSV) monoclonal antibody significantly reduced wheezing and recurrent wheezing among preterm infants.  2. The reduction in wheezing occurred regardless of family history of atopy.  Evidence Rating Level: 1 (Excellent)  Study Rundown: The MAKI trial found that prophylaxis of pre-term infants with the anti-RSV monoclonal...